Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Published Evidence vs Community Protocols Where each AOD-9604 cycle claim comes from Claim AOD-9604 was studied for 12 weeks Published human support Yes, using oral doses Community support Often used as a community timeline How it should be described Published duration, but not a proven SubQ cycle Claim AOD-9604 was studied for 24 weeks Published human support Yes, using oral tablets Community support Sometimes used to justify longer plans How it should be described Published oral trial
Precautions If you need to take a drug through subcutaneous injection often, you may need to rotate the injection sites
AOD-9604 was developed by Australian biotech company Metabolic Pharmaceuticals in the late 1990s as an attempt to isolate the fat-metabolizing properties of growth hormone without its growth-promoting effects
Common protocols suggest 6 to 12 weeks on the compound followed by a break period of roughly half that duration
Hydroxocobalamin: The Long-Lasting Option Then theres hydroxocobalamin, a form of B12 thats a favorite for its staying power
